Hybridoma technologies for antibody production

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  K öhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature256(5517),495–497 (1975).▪▪ Original hybridoma technology for the production of monoclonal antibodies by fusing B lymphocytes with cancerous myeloma cells.
  Medline CASGoogle Scholar
• 2  Benjamini E, Coico R, Sunshine G: Immunology, a Short Course (Fourth Edition). Wiley–Blackwell, NY, USA (2000).
  Google Scholar
• 3  de StGroth SF, Scheidegger D: Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods35(1–2),1–21 (1980).
  Medline CASGoogle Scholar
• 4  Zimmermann U: Electric field-mediated fusion and related electrical phenomena. Biochim. Biophys. Acta694(3),227–277 (1982).▪ Demonstrated improved hybridoma technology by use of pearl-chain formation. The technique brought about relatively high fusion efficiency.
  Medline CASGoogle Scholar
• 5  Ohkohchi N, Itagaki H, Doi H, Taguchi Y, Satomi S, Satoh S: New technique for producing hybridoma by using laser radiation. Lasers Surg. Med.27(3),262–268 (2000).▪ Another improved hybridoma technology using pulse laser, which enabled manually controlled cell fusion under a microscope.
  Medline CASGoogle Scholar
• 6  Lo MMS, Tsong TY, Conrad MK, Strittmatter SM, Hester LD, Snyder SH: Monoclonal antibody production by receptor-mediated electrically induced cell fusion. Nature310(5980),792–794 (1984).▪▪ Original report for the next generation of hybridoma technology based on antigen-based preselection of B lymphocytes and electrical pulses.
  Medline CASGoogle Scholar
• 7  Tsong TY, Tomita M, Lo MMS: Pre-selection of B-lymphocytes by antigen for fusion to myeloma cells by pulsed electric field (PEF) method. In: Molecular Mechanisms of Membrane Fusion. Ohki S, Doyle D, Flanagan TD, Hui SW, Mayhew E (Eds). Plenum, NY, USA, 223–236 (1988).
  Google Scholar
• 8  Tomita M, Tsong TY: Selective production of hybridoma cells: antigenic-based pre-selection of B lymphocytes for electrofusion with myeloma cells. Biochim. Biophys. Acta1055(3),199–206 (1990).
  Medline CASGoogle Scholar
• 9  Tsong TY, Tomita M: Selective B lymphocyte-myeloma cell fusion. Methods Enzymol.220,238–246 (1993).
  Medline CASGoogle Scholar
• 10  Tomita M, Sugi H, Ozawa K, Tsong TY, Yoshimura T: Targeting antigen-specific receptors on B lymphocytes to generate high yields of specific monoclonal antibodies directed against biologically active lower antigenic peptides within presenilin 1. J. Immunol. Methods251(1–2),31–43 (2001).
  Medline CASGoogle Scholar
• 11  Tomita M, Fukuda T, Ozu A, Kimura K, Tsong TY, Yoshimura T: Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity. Hybridoma (Larchmt) 25(5),283–292 (2006).▪ Three critical steps of B-cell targeting were first corroborated on the basis of immunofluorescence analysis.
  Medline CASGoogle Scholar
• 12  Tomita M: Next generation of monoclonal antibodies. BIOforum Europe12(4),33–34 (2008).
  CASGoogle Scholar
• 13  Tomita M: A novel method for generation of monoclonal antibodies. In: Biochemistry and Histocytochemistry Research Developments (Expert Commentary). Fuchs S, Auer M (Eds). Nova Science Publishers, NY, USA, 335–336 (2010).
  Google Scholar
• 14  Tomita M, Tsumoto K: Recent advances in antigen-based generation of monoclonal antibodies. Curr. Immunol. Rev.6(1),56–61 (2010).▪ Review of antigen-based generation of monoclonal antibodies.
  CASGoogle Scholar
• 15  Chaiet L, Wolf FJ: The properties of streptavidin, a biotin-binding protein produced by streptomycetes. Arch. Biochem. Biophys.106,1–5 (1964).
  Medline CASGoogle Scholar
• 16  Green NM: Avidin. Adv. Protein Chem.29,85–133 (1975).
  Medline CASGoogle Scholar
• 17  Wojchowski DM, Sytkowski AJ: Hybridoma production by simplified avidin-mediated electrofusion. J. Immunol. Methods90(2),173–177 (1986).
  Medline CASGoogle Scholar
• 18  Hewish DR, Werkmeister JA: The use of an electroporation apparatus for the production of murine hybridomas. J. Immunol. Methods120(2),285–289 (1989).
  Medline CASGoogle Scholar
• 19  Werkmeister JA, Tebb TA, Kirkpatrick A, Shukla DD: The use of peptide-mediated electrofusion to select monoclonal antibodies directed against specific and homologous regions of the potyvirus coat protein. J. Immunol. Methods143(2),151–157 (1991).
  Medline CASGoogle Scholar
• 20  Woolley DW, Longsworth LG: Isolation of an antibiotin factor from egg white. J. Biol. Chem.142(1),285–290 (1942).
  CASGoogle Scholar
• 21  Tomita M, Yokota T, Wada M et al.: Nanosensing measurement using novel monoclonal antibodies generated by B-cell targeting. FEBS J.275(Suppl. 1),373 (2008).
  Google Scholar
• 22  Boss BD: An improved in vitro immunization procedure for the production of monoclonal antibodies. Methods Enzymol.121,27–33 (1986).
  Medline CASGoogle Scholar
• 23  Tomita M, Taniguchi T, Tanaka J et al.: Generation of monoclonal antibodies directed against peptide sequences by a B cell targeting technique. Hum. Antibodies12(1–2),37–39 (2003).
  Google Scholar
• 24  Tomita M, Sugao M, Taniguchi T et al.: Antigen-based B cell targeting technique to generate high yields of monoclonal antibodies. Hum. Antibodies13(1–2),42 (2004).
  Google Scholar
• 25  Tomita M, Taniguchi T, Sawada H, Nishino N, Yoshimura T: Rapid generation of monoclonal antibodies against the epitope sequences of human insulin using an in vitro immunization method. Peptide Sci.469–472 (2004).
  Google Scholar
• 26  Tomita M, Asaoka Y, Kato Y, Ogata S, Tsong TY, Yoshimura T: A new technology for the generation of novel monoclonal antibodies based on short-term immunization. Peptide Sci.105–108 (2006).
  Google Scholar
• 27  Tomita M, Asaoka Y, Fukuda T et al.: Rapid and selective production of hybridoma cells secreting novel monoclonal antibodies based on short-term immunization. Hum. Antibodies15(1–2),33–35 (2006).
  Google Scholar
• 28  Gavilondo JV, Larrick JW: Antibody engineering at the millennium. BioTechniques29(1),128–145 (2000).
  Medline CASGoogle Scholar
• 29  Konthur Z, Hust M, Dübel S: Perspectives for systematic in vitro antibody generation. Gene364,19–29 (2005).
  Medline CASGoogle Scholar
• 30  Wark KL, Hudson PJ: Latest technologies for the enhancement of antibody affinity. Adv. Drug Deliv. Rev.58(5–6),657–670 (2006).
  Medline CASGoogle Scholar
• 31  Bradbury AR, Marks JD: Antibodies from phage antibody libraries. J. Immunol. Methods290(1–2),29–49 (2004).
  Medline CASGoogle Scholar
• 32  Border ET, Midelfort KS, Wittrup KD: Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl Acad. Sci. USA97(20),10701–10705 (2000).
  MedlineGoogle Scholar
• 33  Feldhaus MJ, Siegel RW: Yeast display of antibody fragments: a discovery and characterization platform. J. Immunol. Methods290(1–2),69–80 (2004).
  Medline CASGoogle Scholar
• 34  Lipovsek D, Plückthun A: In-vitro protein evolution by ribosome display and mRNA display. J. Immunol. Methods290(1–2),51–67 (2004).
  Medline CASGoogle Scholar
• 35  Løvborg U: Monoclonal Antibodies: Production and Maintenance. William Heinemann Medical Books, London, UK (1982).
  Google Scholar
• 36  Tomita M, Furuta K, Sano Y, Tsumoto K: Multiple generation of novel monoclonal antibodies based on B-cell targeting. FEBS J.276(Suppl. 1),293 (2009).
  Google Scholar
• 37  TOMITA M, MATSUBA T: JP4599527 (2010).
  Google Scholar
• 38  Tomita M, Hirano M, Watanabe E et al.: A new technology for intact antigen-based and receptor-mediated generation of novel monoclonal antibodies. Hum. Antibodies16(1–2),40–41 (2007).
  Google Scholar
• 39  Tomita M, Tsumoto K: New hybridoma technology based on antigen-specific immunoglobulin receptors. FEBS J.277(Suppl. 1),50 (2010).
  Google Scholar
• 40  Lonberg N, Taylor LD, Harding FA et al.: Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature368(6474),856–859 (1994).
  Medline CASGoogle Scholar
• 41  Green LL, Hardy MC, Maynard-Currie CE et al.: Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat. Genet.7(1),13–21 (1994).
  Medline CASGoogle Scholar
• 42  Jakobovits A: Production of fully human antibodies by transgenic mice. Curr. Opin. Biotechnol.6(5),561–566 (1995).
  Medline CASGoogle Scholar
• 43  Matsumoto N, Matsue T, Uchida I: Paired cell alignment using jagged microarray electrode. Bioelectrochem. Bioenerg.34(2),199–202 (1994).
  CASGoogle Scholar
• 44  Ho CT, Lin RZ, Chang WY, Chang HY, Liu CH: Rapid heterogeneous liver-cell on-chip patterning via the enhanced field-induced dielectrophoresis trap. Lab. Chip6(6),724–734 (2006).
  Medline CASGoogle Scholar
• 45  Heida T, Rutten WLC, Marani E: Dielectrophoretic trapping of dissociated fetal cortical rat neurons. IEEE Trans. Biomed. Eng.48(8),921–930 (2001).
  Medline CASGoogle Scholar
• 46  Gray DS, Tan JL, Voldman J, Chen CS: Dielectrophoretic registration of living cells to a microelectrode array. Biosens. Bioelectron.19(12),1765–1774 (2004).
  Medline CASGoogle Scholar
• 47  Yu Z, Xiang G, Pan L et al.: Negative dielectrophoretic force assisted construction of ordered neuronal networks on cell positioning bioelectronic chips. Biomed. Microdevices6(4),311–324 (2004).
  Medline CASGoogle Scholar
• 48  Suzuki M, Yasukawa T, Shiku H, Matsue T: Negative dielectrophoretic patterning with different cell types. Biosens. Bioelectron.24(4),1043–1047 (2008).
  CASGoogle Scholar
• 49  Jat PS, Noble MD, Ataliotis P et al.: Direct derivation of conditionally immortal cell lines from an H-2K^b-tsA58 transgenic mouse. Proc. Natl Acad. Sci. USA88(12),5096–5100 (1991).
  Medline CASGoogle Scholar
• 50  Pasqualini R, Arap W: Hybridoma-free generation of monoclonal antibodies. Proc. Natl Acad. Sci. USA101(1),257–259 (2004).
  Medline CASGoogle Scholar
• 51  Matsuba T, Mitoma Y, Tanaka C, Inoue M: Preparation of super-high affinity rabbit monoclonal antibodies against estradiol. Application to highly sensitive estradiol measurement. Tosoh Res. Technol. Rev.52,3–9 (2008).
  Google Scholar
• 52  MATSUBA T: JP2009240300 (2009).
  Google Scholar
• 53  MASUBUCHI H, HASHIMOTO S: JP1998262657 (1998).
  Google Scholar
• 54  Zhou X, Hu W, Qin X: The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy. Oncologist13(9),954–966 (2008).
  Medline CASGoogle Scholar
• 55  Kubota T, Niwa R, Satoh M, Akinaga S, Shitara K, Hanai N: Engineered therapeutic antibodies with improved effector functions. Cancer Sci.100(9),1566–1572 (2009).
  Medline CASGoogle Scholar